Valuation: CVRx, Inc.

Market Cap 79.13M 69.13M 64.93M 59.3M 111M 7.56B 111M 778M 300M 3.86B 297M 291M 12.46B P/E 2026 *
-1.43x
P/E 2027 * -1.51x
Enterprise Value 89.63M 78.31M 73.55M 67.18M 126M 8.57B 126M 881M 340M 4.38B 337M 329M 14.12B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.84x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-2.69%
1 week-3.67%
Current month-2.36%
1 month+1.76%
3 months-41.62%
6 months-66.74%
Current year-59.30%
1 week 2.86
Extreme 2.86
3.13
1 month 2.7
Extreme 2.7
3.42
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 A Buy

Chief Operating Officer

26,223 0.0988%
8/12/26 A Sell

Chief Operating Officer

-1,309 0.0049%
6/1/26 A
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-2.69%-3.67%-59.69%-80.27% 79.13M
+0.19%-0.15%+24.96%+27.57% 12.56B
+1.95%+3.15%+16.46%+23.68% 6.67B
+0.38%-3.50% - - 5.94B
-0.21%+0.74%+28.03%+21.61% 5.52B
-0.03%-1.96%-19.13%+39.04% 5.06B
+0.76%+4.20%-31.52%-21.85% 3.92B
+0.85%+2.77%+31.36%-5.23% 1.92B
+0.87%-4.92%-19.78%+170.40% 1.66B
-1.95%+0.60%+48.74%-15.31% 1.57B
Average +0.01%-0.04%+2.16%+17.74% 4.49B
Weighted average by Cap. +0.43%+0.08%+11.72%+25.08%

Financials

2026 *2027 *
Net sales 58.85M 51.42M 48.29M 44.11M 82.78M 5.63B 82.73M 579M 223M 2.87B 221M 216M 9.27B 66.18M 57.82M 54.31M 49.6M 93.08M 6.33B 93.03M 651M 251M 3.23B 249M 243M 10.42B
Net income -53.45M -46.7M -43.86M -40.06M -75.18M -5.11B -75.14M -526M -203M -2.61B -201M -196M -8.42B -52.14M -45.55M -42.78M -39.07M -73.33M -4.98B -73.29M -513M -198M -2.55B -196M -191M -8.21B
Net Debt 10.5M 9.18M 8.62M 7.87M 14.77M 1B 14.76M 103M 39.84M 513M 39.44M 38.58M 1.65B 42.94M 37.51M 35.23M 32.18M 60.39M 4.1B 60.36M 422M 163M 2.1B 161M 158M 6.76B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
22/09/26 $2.890 -2.69% 665,900
21/09/26 $2.970 -2.30% 289,629
18/09/26 $3.040 +1.33% 810,573
17/09/26 $3.000 -0.66% 301,154
16/09/26 $3.020 +0.67% 415,886
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.970USD
Average target price
4.583USD
Spread / Average Target
+54.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!